Dr. Daniel P. Nolan, DO
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Midwestern University, Chicago College of Osteopathic Med (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 1,048
Licensed in Texas since 2017, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: Midwestern University, Chicago College of Osteopathic Med
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
TX license R3566 (first issued 2017; active) - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Medical Center Ophthalmology Associates (12 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,048
- Services billed
- 4,683
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient problem focused exam of visual system | 924 | 612 |
| Established patient complete exam of visual system | 871 | 795 |
| Exam of visual field with extended testing | 604 | 508 |
| Imaging of optic nerve | 559 | 532 |
| Exam of the internal drainage system of eye | 385 | 369 |
| Ultrasound scan of cornea to determine thickness | 294 | 286 |
| Measurement of corneal curvature and depth of eye | 260 | 175 |
| Removal of cataract with insertion of prosthetic lens | 193 | 128 |
| New patient complete exam of visual system | 114 | 114 |
| Imaging of retina | 64 | 63 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in San Antonio, TX | 1,336 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in San Antonio, TX | 968 |
| Prednisolone Acetate Other prescribers in San Antonio, TX | 533 |
| Moxifloxacin (moxifloxacin hcl) Other prescribers in San Antonio, TX | 505 |
| Timolol Maleate Other prescribers in San Antonio, TX | 503 |
| Brimonidine Tartrate Other prescribers in San Antonio, TX | 350 |
| Lumigan (bimatoprost) Other prescribers in San Antonio, TX | 290 |
| Dorzolamide Hcl Other prescribers in San Antonio, TX | 235 |
| Ketorolac Tromethamine Other prescribers in San Antonio, TX | 216 |
| Rhopressa (netarsudil mesylate) | 166 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $94.05 in total to this clinician.
| Tarsus Pharmaceuticals, Inc. | $29.10 |
|---|---|
| Alcon Vision LLC | $24.03 |
| AbbVie Inc. | $21.43 |
| Amgen Inc. | $19.49 |
| Food and Beverage | $94.05 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $19,215 in research payments for these studies, mostly to the institutions running them.
- Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
AbbVie Inc. · Completed · NCT03850782
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.